Potent bactericidal constituents from Mallotus philippinensis against clarithromycin and metronidazole resistant strains of Japanese and Pakistani Helicobacter pylori.

In the quest for potent anti-Helicobacter pylori agents, we found 70% EtOH extract of Mallotus philippinensis (LAM.) MUELL. (MPM) with strong bactericidal activity at the concentration of 15.6-31.2 mg/l against eight H. pylori strains. Further fractionation and purification of 70% EtOH extract of MPM led to the isolation of 5 compounds, namely 5,7-dihydroxy-8-methyl-6-prenylflavanone (1), 3'-prenylrubranine (2), red compound (3), isorottlerin (4), and rottlerin (5) which were elucidated on the basis of nuclear magnetic resonance and mass spectroscopy. Among the isolated compounds, rottlerin exhibited most potent bactericidal activity with minimum bactericidal concentration (MBC) value of 3.12-6.25 mg/l against several clinical H. pylori isolates including Japanese and Pakistani strains, nine clarithromycin resistant (CR), and seven metronidazole resistant (MR) strains. Minimum inhibitory concentration (MIC) values of CR (8->256 mg/l) and MR (>256 mg/l) strains were analyzed by E test. Moreover, the clarithromycin resistant strains were evaluated for A2143G and A2144G point mutations of 23s rRNA gene to correlate the MBC values with mutation type. Our results revealed the potent in vitro anti-H. pylori activity of MPM and rottlerin, specially against CR and MR strains, which could be gainfully utilized for the development of novel antimicrobials to prevent H. pylori related disorders.

[1]  A. Zuckerman,et al.  IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 1995, IARC monographs on the evaluation of carcinogenic risks to humans.

[2]  T. Sugiyama,et al.  Bactericidal activity of medicinal plants, employed for the treatment of gastrointestinal ailments, against Helicobacter pylori. , 2009, Journal of ethnopharmacology.

[3]  M. Sasatsu,et al.  Mutations in the 23S rRNA gene of clarithromycin-resistant Helicobacter pylori from Japan. , 2007, International journal of antimicrobial agents.

[4]  S. Soltoff,et al.  Rottlerin: an inappropriate and ineffective inhibitor of PKCdelta. , 2007, Trends in pharmacological sciences.

[5]  Z. Iqbal,et al.  An inventory of the ethnobotanicals used as anthelmintics in the southern Punjab (Pakistan). , 2006, Journal of ethnopharmacology.

[6]  H. Padh,et al.  Search for antibacterial and antifungal agents from selected Indian medicinal plants. , 2006, Journal of ethnopharmacology.

[7]  Tetsuro Ito,et al.  Novel, Complex Flavonoids from Mallotus philippensis (Kamala Tree) , 2005 .

[8]  J. Armstrong,et al.  Microbiological aspects ofHelicobacter pylori (Campylobacter pylori) , 2005, European Journal of Clinical Microbiology and Infectious Diseases.

[9]  M. Asaka,et al.  Helicobacter pylori infection and gastric cancer , 2004, Medical Electron Microscopy.

[10]  M. Asaka,et al.  Helicobacter pylori and Gastric Malignancies , 2002, Helicobacter.

[11]  M. Asaka,et al.  Up-regulated Smad5 Mediates Apoptosis of Gastric Epithelial Cells Induced by Helicobacter pylori Infection* , 2003, The Journal of Biological Chemistry.

[12]  S. Suerbaum,et al.  Helicobacter pylori infection , 2013, Nature Reviews Disease Primers.

[13]  S. Kitanaka,et al.  Anti-allergic agents from natural sources (4): anti-allergic activity of new phloroglucinol derivatives from Mallotus philippensis (Euphorbiaceae). , 2002, Chemical & pharmaceutical bulletin.

[14]  E. Ernst,et al.  Herbal medicinal products for non‐ulcer dyspepsia , 2002, Alimentary pharmacology & therapeutics.

[15]  Ahmedin Jemal,et al.  Cancer Statistics, 2002 , 2002, CA: a cancer journal for clinicians.

[16]  T. Fujioka,et al.  A Multicenter, Double‐Blind Study on Triple Therapy with Lansoprazole, Amoxicillin and Clarithromycin for Eradication of Helicobacter pylori in Japanese Peptic Ulcer Patients , 2001, Helicobacter.

[17]  K. Wilson,et al.  Modulation of Innate Cytokine Responses by Products of Helicobacter pylori , 2000, Infection and Immunity.

[18]  A. Munakata,et al.  Clarithromycin‐resistance and point mutations in the 23S rRNA gene in Helicobacter pylori isolates from Japan , 2000, Journal of gastroenterology and hepatology.

[19]  J. Pedrazzoli,et al.  Prevalence of Helicobacter pylori Resistance to Metronidazole, Clarithromycin, Amoxicillin, Tetracycline, and Furazolidone in Brazil , 2000 .

[20]  D. Hill,et al.  Activities of Garlic Oil, Garlic Powder, and Their Diallyl Constituents against Helicobacter pylori , 2000, Applied and Environmental Microbiology.

[21]  R. Rappuoli,et al.  Helicobacter pylori virulence and genetic geography. , 1999, Science.

[22]  S. Suerbaum,et al.  Primary and Acquired Helicobacter pylori Resistance to Clarithromycin, Metronidazole, and Amoxicillin—Influence on Treatment Outcome , 1998, American Journal of Gastroenterology.

[23]  T. Azuma,et al.  Susceptibility of Helicobacter pylori isolates to metronidazole, clarithromycin and amoxycillin in vitro and in clinical treatment in Japan , 1997, Alimentary pharmacology & therapeutics.

[24]  D. Graham,et al.  Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance. , 1997, The Journal of antimicrobial chemotherapy.

[25]  F. Mégraud Resistance of Helicobacter pylori to antibiotics , 1997, Alimentary pharmacology & therapeutics.

[26]  E Hentschel,et al.  Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. , 1993, The New England journal of medicine.

[27]  B. Shalmon,et al.  Scale-up of two-impinging-streams (TIS) reactors , 1988 .

[28]  A. Huhtikangas,et al.  On the phloroglucinol derivatives of Mallotus philippinensis. , 1975, Planta medica.